Drug Delivery for Cancer Immunotherapy and Vaccines

Pharmaceutical Nanotechnology
Cole J BattyKristy M Ainslie

Abstract

Cancer cells are able to avoid immune surveillance and exploit the immune system to grow and metastasize. With the development of nano- and micro-particles, there has been a growing number of immunotherapy delivery systems developed to elicit innate and adaptive immune responses to eradicate cancer cells. This can be accomplished by training resident immune cells to recognize and eliminate cells with tumor-associated antigens or by providing external stimuli to enhance tumor cell apoptosis in the immunosuppressive tumor microenvironment (TME). In this review we will focus on nano- and micro-particle (NP and MP) based immunotherapies and vaccines used to elicit a potent and sustained antitumor immune response.

Citations

Feb 14, 2021·Biomaterials·Fangmin ChenHaijun Yu
May 23, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Adam M SandorJenny P Y Ting

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Critical Reviews in Oncogenesis
Claudia Gravekamp, Dinesh Chandra
Frontiers in Immunology
Shiny Nair, Madhav V Dhodapkar
© 2022 Meta ULC. All rights reserved